Emergence of CTX-M-3, TEM-1 and a new plasmid-mediated MOX-4 AmpC in a multiresistant Aeromonas caviae isolate from a patient with pneumonia

J Med Microbiol. 2010 Jul;59(Pt 7):843-847. doi: 10.1099/jmm.0.016337-0. Epub 2010 Mar 25.

Abstract

Aeromonas species rarely cause pulmonary infection. We report, for what is believed to be the first time, a case of severe pneumonia in a cancer patient caused by Aeromonas caviae. Detailed microbiological investigation revealed that this isolate carried three beta-lactamase-encoding genes (encoding MOX-4, CTX-M-3 and TEM-1) conferring resistance to all beta-lactams but imipenem. The beta-lactamase with a pI of 9.0 was transferred by conjugation and associated with a 7.3 kb plasmid, as demonstrated by Southern blot hybridization. Analysis of the nucleotide and amino acid sequences showed a new ampC gene that was closely related to those encoding the MOX-1, MOX-2 and MOX-3 beta-lactamases. This new plasmid-mediated AmpC beta-lactamase from China was named MOX-4. This is believed to be the first report of MOX-4, CTX-M-3 and TEM-1 beta-lactamases in a multiresistant A. caviae.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aeromonas / classification
  • Aeromonas / drug effects*
  • Aged
  • Amino Acid Sequence
  • Anti-Bacterial Agents / pharmacology
  • Bacterial Proteins / chemistry
  • Bacterial Proteins / genetics
  • Bacterial Proteins / metabolism*
  • Communicable Diseases, Emerging
  • Drug Resistance, Multiple, Bacterial / genetics
  • Gene Expression Regulation, Bacterial / physiology
  • Gram-Negative Bacterial Infections / microbiology*
  • Humans
  • Male
  • Plasmids / genetics
  • Pneumonia, Bacterial / microbiology*
  • beta-Lactamases / chemistry
  • beta-Lactamases / genetics
  • beta-Lactamases / metabolism*

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • beta-Lactamases